Sign in

Blas Chaves-Urbano

@blaschaves.bsky.social
67 followers 179 following 2 posts

PhD student at CNIO, Madrid, Spain | La Caixa INPhINIT Retaining Fellow

PostsRepliesMedia
Reposted by Blas Chaves-Urbano
Barbara Hernando @bhernando.bsky.social · 12/09/2026
1/ NEW PAPER 🎉 🧵 We mapped the mutational processes shaping 959 prostate cancer genomes from the Pan Prostate Cancer Group (PPCG), integrating SBS, ID, CX and complex SV signatures. Eight footprints account for the processes in 85% of cases www.nature.com/articles/s41... @nature.com
nature.com
Integrated signatures define mutational processes in prostate cancer - Nature
Eight integrated mutational footprints collectively explain the mutational processes in 85% of primary prostate cancer genomes.
154
Reposted by Blas Chaves-Urbano
Barbara Hernando @bhernando.bsky.social · 28/11/2025
📢 New preprint out! We are thrilled to introduce our framework to track #ongoingCIN by leveraging single-cell genomics and CIN signatures: www.biorxiv.org/content/10.1...
biorxiv.org
Tracking ongoing chromosomal instability using single-cell whole-genome sequencing
Chromosomal instability (CIN) generates aneuploid genomes that are characteristic of most cancers. While bulk genome sequencing reveals historical CIN, it lacks the resolution to identify ongoing CIN ...
2164
Reposted by Blas Chaves-Urbano
Geoff Macintyre @gmaci.bsky.social · 23/06/2025
🚨Chemo treatment upgrade!🚨 Check out our approach to modernise chemotherapy treatment published today in @natgenet.nature.com. From @cniostopcancer.bsky.social #TailorBio @cruk-ci.bsky.social www.nature.com/articles/s41... More details 👇
nature.com
1179
Reposted by Blas Chaves-Urbano
Nature Genetics @natgenet.nature.com · 23/06/2025
📢OUT TODAY @natgenet.nature.com 📰Predicting resistance to chemotherapy using chromosomal instability signatures. By @jsneaththompson.bsky.social, @gmaci.bsky.social and colleagues. ⬇️ www.nature.com/articles/s41...
nature.com
Predicting resistance to chemotherapy using chromosomal instability signatures - Nature Genetics
Here the authors show that chromosomal instability signatures can predict resistance to anthracycline-, taxane- and platinum-based chemotherapeutics in breast, ovarian and prostate cancer and sarcoma....
063
Reposted by Blas Chaves-Urbano
Cancer Research UK Cambridge Institute @cruk-ci.bsky.social · 23/06/2025
The days of one-size-fits-all chemotherapy are ending. Researchers at our Institute, @cniostopcancer.bsky.social & Tailor Bio have developed a test that predicts resistance to common chemo drugs — paving the way for personalised cancer treatment. Find out more 👉 www.cruk.cam.ac.uk/news/scienti...
033
Reposted by Blas Chaves-Urbano
cniostopcancer.bsky.social @cniostopcancer.bsky.social · 23/06/2025
The paper is published in @natgenet.nature.com. First authors: @bhernando.bsky.social, @jsneaththompson.bsky.social and Laura Madrid. With collaborations from Tailor Bio and @cam.ac.uk.  Funding: @saludisciii.bsky.social @cienciagob.bsky.social  @cruk-ci.bsky.social  y @lacaixa.bsky.social
122
Blas Chaves-Urbano @blaschaves.bsky.social · 17/06/2025
A pleasure to be at the fantastic #EACR2025 and present my research project! Looking forward for cool scientific discussions with amazing cancer researchers and friends @helloeacr.bsky.social @cniostopcancer.bsky.social @gmaci.bsky.social
091
Reposted by Blas Chaves-Urbano
Geoff Macintyre @gmaci.bsky.social · 10/06/2025
If tumour genome evolution is deterministic, can we forecast genomic changes? Yes we can! At least for oncogene amps and tumour suppressor dels. @bhernando.bsky.social Angel Fernandez-Sanroman present our method for forecasting driver gene copy number change. Preprint: bit.ly/4kxF14y ⬇️1/
bit.ly
Forecasting oncogene amplification and tumour suppressor deletion
Oncogene amplification and tumour suppressor deletion can drive tumour initiation, progression and treatment resistance. Detection at diagnosis often signals poor prognosis, but it can also enable opp...
133
Reposted by Blas Chaves-Urbano
Geoff Macintyre @gmaci.bsky.social · 16/01/2025
We are hiring! Opportunity for a project manager to oversee all aspects of a multi-centre clinical research project to implement an AI-based genomic test that predicts resistance to chemotherapy - Madrid, Spain. PM for more details. Deadline 25 January! www.cnio.es/en/empleo/re...
013